Pfizer Inc
Stocks making the biggest moves in the premarket: Peloton, Novavax, Vroom and more
Take a look at some of the biggest movers in the premarket: Peloton (PTON) – Peloton shares plunged 25.8% in the premarket after the fitness equipment maker reported a larger-than-expected quarterly loss and projected current-quarter revenue below estimates due to softening demand. Novavax (NVAX) – Novavax sank 23% in premarket trading after the vaccine maker […]
Read More
U.S. will limit next generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding
The U.S. will have to limit the next generation of Covid vaccines this fall to individuals at the highest risk of getting seriously sick from the virus if Congress fails to approve funding to purchase the new shots, according to a senior Biden administration official. The official, who spoke on condition of anonymity, warned that […]
Read More
Kevin O’Leary says there are plenty of good places to ‘hide’ as interest rates rise
As interest rates in the U.S. rise, investors can put their money to work by looking at companies in the S&P 500 that can “increase their prices” and “maintain margins,” Kevin O’Leary told CNBC. “There’s plenty of them. That’s a good place to hide when you’re getting a 2% dividend yield,” the celebrity investor said […]
Read More
Cramer’s lightning round: Chubb is ‘a great company’
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed. Source
Read More
5 things to know before the stock market opens Friday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Futures drop after worst day for Dow, Nasdaq since 2020 A trader works on the trading floor at the New York Stock Exchange (NYSE) in New York, May 5, 2022. Andrew Kelly | Reuters U.S. stock futures […]
Read More
Paxlovid prescriptions to treat Covid increased tenfold in U.S. since late February, Pfizer says
Pfizer on Tuesday said prescriptions for its oral antiviral to treat Covid-19 have increased tenfold in the U.S. since late February, as more pharmacies and other locations receive supply. CEO Albert Bourla, in an earnings call Tuesday morning, said nearly 80,000 patients were treated with Paxlovid in the U.S. the week ending April 22, up […]
Read More
Stocks making the biggest moves midday: Chegg, Expedia, BP and more
James Tahaney loads textbooks on to a pallet in preparation for shipping at the Chegg warehouse in Shepherdsville, Kentucky, April 29, 2010. John Sommers II | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Paramount Global – Shares fell 1.7% after the entertainment giant reported first-quarter revenue below expectations. The […]
Read More
5 things to know before the stock market opens Tuesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures are lower after Monday’s intraday reversal Traders work on the floor of the New York Stock Exchange (NYSE) on April 25, 2022 in New York City. Spencer Platt | Getty Images Stock futures were slightly […]
Read More
Stocks making the biggest moves in the premarket: Paramount Global, Logitech, Chegg and more
Take a look at some of the biggest movers in the premarket: Paramount Global (PARA) – Paramount Global fell 4.3% in the premarket, despite quarterly profit that beat Wall Street estimates. Revenue came in below analysts’ forecasts for the media company, amid increasing video streaming competition and weak ad sales growth. Logitech (LOGI) – Logitech […]
Read More
Pfizer reports combined sales of $15 billion for Covid vaccine and antiviral treatment in first quarter
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer beat on its top and bottom line in its first quarter earnings report, driven by strong sales of its Covid vaccine and oral antiviral treatment. The pharmaceutical giant […]
Read More